Global Coronary Heart Disease Epidemiology and Patient Flow Analysis - 2016

Global Coronary Heart Disease Epidemiology and Patient Flow Analysis - 2016

  • January 2016 •
  • Report ID: 3895240 •
  • Format: PDF
Fore Pharma announced the results of its Coronary Heart Disease patient population study in a new report ‘Global Coronary Heart Disease Epidemiology and Patient Flow Analysis - 2016’. The report provides insights into Coronary Heart Disease epidemiology, Coronary Heart Disease diagnosed patients, and Coronary Heart Disease treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Coronary Heart Disease derived from epidemiological analysis, percentage of patients diagnosed with Coronary Heart Disease, and percentage of patients treated with Coronary Heart Disease therapy.

The study helps executives estimate Coronary Heart Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Coronary Heart Disease prevalence, Coronary Heart Disease diagnosis rate, and Coronary Heart Disease treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Coronary Heart Disease: Disease Definition
- Coronary Heart Disease Patient Flow
- Coronary Heart Disease Prevalence
- Coronary Heart Disease Diagnosed Patients
- Coronary Heart Disease Treated Patients